Kastia (Rosuvastatin)

Rosuvastatin works by inhibiting HMG‑CoA reductase, the key enzyme in the liver responsible for producing cholesterol. This inhibition lowers intracellular cholesterol, prompting the liver to increase the number of LDL receptors, which clear more low‑density lipoprotein cholesterol from the bloodstream.

The appropriate dose of Kastia is determined by the prescribing healthcare professional based on the patient’s clinical condition, cholesterol levels, and response to therapy. Dosage may be adjusted over time to achieve target lipid goals while monitoring safety.

The safety of rosuvastatin in pregnancy and lactation has not been established. It is generally contraindicated for use in pregnant or nursing women because potential risks to the fetus or infant cannot be ruled out. Alternative lipid‑lowering strategies should be considered.

To place an order, submit an enquiry on the Kastia product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Kastia (rosuvastatin) is a high‑potency statin that often achieves greater LDL‑C reductions at lower doses compared with older agents such as simvastatin or pravastatin. Its pharmacokinetic profile provides a longer half‑life, allowing for consistent lipid control, but individual response and tolerability should guide therapy selection.

Kastia tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Kastia is taken orally, usually once daily, with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water and follow any specific instructions regarding timing relative to meals.

The most serious risks include rhabdomyolysis, a rare but severe muscle breakdown that can lead to kidney injury, and significant liver enzyme elevations indicating potential hepatotoxicity. Patients should report unexplained muscle pain, weakness, dark urine, or signs of liver dysfunction promptly.

Kastia should not be used by individuals with known hypersensitivity to rosuvastatin or any component of the formulation, patients with active liver disease, or those who are pregnant or breastfeeding. Caution is also advised for patients with severe renal impairment or those taking interacting medications without proper monitoring.